CaseTrail

United States v. Generix Drug Corp.

460 U.S. 453 · Decided March 22, 1983 · Supreme Court of the United States

Record summary. This page is generated from the Supreme Court Database’s coded data about the case. It describes who decided what, not the Court’s reasoning. Read the opinion itself before relying on it. Not legal advice.

At a glance

United States v. Generix Drug Corp. was decided on March 22, 1983 unanimously (9–0). The Court reversed the lower court's decision. Justice John Paul Stevens wrote the opinion of the Court. SCDB classifies its main issue as “Consumer protection” in the Economic Activity area.

Read the opinion

Case details

Citations
460 U.S. 453 · 103 S. Ct. 1298 · 75 L. Ed. 2d 198 · 1983 U.S. LEXIS 149
Docket number
81-1222
Decided
March 22, 1983
Argued
November 3, 1982
Court era
Burger Court
Decision type
Opinion of the Court (orally argued)
Disposition
Reversed
Outcome for petitioner
The petitioning party received a favorable disposition
Vote
9–0 (unanimous)
Majority opinion
John Paul Stevens
Opinion assigned by
Warren E. Burger
How the case arrived
Certiorari
Legal provision
Federal Food, Drug, and Cosmetic Act
Type of law
Federal statute
Decision direction (SCDB)
Liberal what this means

How the Justices voted

Full case caption

United States v. Generix Drug Corp. et al.

SCDB identifiers: case 1982-044, docket 1982-044-01.

Other cases on “Consumer protection”

See all

Cases on the same legal provision: Federal Food, Drug, and Cosmetic Act

Same Term, same area (Economic Activity)

See all

Source: Supreme Court Database, 2026 Release 01 (data file dated September 8, 2026). Imported into CaseTrail November 5, 2026. Coverage: decisions from the 1946 through 2025 Terms. Methodology · Report an error